drugset / Trial / NCT03016611

Chewing Ticagrelor Versus Prasugrel in ST-elevation Myocardial Infarction - A Platelet Reactivity Study

NCT03016611

Phase 4 Unknown 100 enrolled Sheba Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

To examine the efficacy of chewing Ticagrelor versus Prasugrel in ST-elevation Myocardial Infarction (STEMI) patients on platelet reactivity.

Timeline

Start
2017-02
Primary completion
2017-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prasugrel Small molecule 60 mg
Subject Ticagrelor Small molecule 180 mg